未登录

T

Thilak Mudalige

us food & drug administration (fda)

H指数:22

被引数:1,347

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluation of size-based distribution of components in VYXEOS® liposomal formulation using asymmetric flow field-flow fractionation

JOURNAL OF CHROMATOGRAPHY A

IF4

2024-12-010

PRE

A Robust Chromatographic Method for Drug Release profiling of liposomal doxorubicin HCl

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2024-09-010

PRE

Excipient-related impurities in liposome drug products

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2024-05-011

PRE

An Automated Capillary Electrophoresis Based Method for Drug Release Pro fi ling of Liposomal Doxorubicin

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2024-04-013

PRE

An Automated Electroanalytical Method for the Drug Release Profiling of Liposomal Doxorubicin HCl Formulations

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2024-03-013

PRE

Profiling in-vitro release of verteporfin from VISUDYNE® liposomal formulation and investigating verteporfin binding to human serum albumin

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2023-11-011

OAAI

Analysis of phospholipids and triacylglycerols in intravenous lipid emulsions

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2023-01-014

OAAI

Analysis of verteporfin liposomal formulations for phospholipids and phospholipid degradation products by liquid chromatography-mass spectrometry (LC-MS)

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2022-01-019

OAAI

Quantification of phospholipid degradation products in liposomal pharmaceutical formulations by ultra performance liquid chromatography-mass spectrometry (UPLC-MS)

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2020-03-0123

OAAI

Characterization of doxorubicin liposomal formulations for size-based distribution of drug and excipients using asymmetric-flow field-flow fractionation (AF4) and liquid chromatography-mass spectrometry (LC-MS)

使用不对称流场流分级 (AF4) 和液相色谱-质谱 (lc-ms) 表征阿霉素脂质体制剂，用于药物和赋形剂的基于大小的分布

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2020-01-0124

OAAI

Evaluation of size-based distribution of drug and excipient in amphotericin B liposomal formulation

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2019-10-0120

PREAI

Quantitative analysis of cholesterol oxidation products and desmosterol in parenteral liposomal pharmaceutical formulations

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2019-10-0121

PREAI

Direct and simultaneous determination of intra-liposomal and external sulfate in liposomal doxorubicin formulations by capillary electrophoresis/inductively coupled plasma-tandem mass spectrometry (CE/ICP-MS/MS)

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2019-04-0122

OAAI

Direct quantification of unencapsulated doxorubicin in liposomal doxorubicin formulations using capillary electrophoresis

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2018-10-0130

OAAI

Capillary electrophoresis and asymmetric flow field-flow fractionation for size-based separation of engineered metallic nanoparticles: A critical comparative review

TRAC-TRENDS IN ANALYTICAL CHEMISTRY

IF12

2018-09-0140

PREAI

Cellular and Molecular Effects of Prolonged Low-Level Sodium Arsenite Exposure on Human Hepatic HepaRG Cells

TOXICOLOGICAL SCIENCES

IF4.1

2018-01-0221

OAAI

RapidFire Mass Spectrometry with Enhanced Throughput as an Alternative to Liquid-Liquid Salt Assisted Extraction and LC/MS Analysis for Sulfonamides in Honey

ANALYTICAL CHEMISTRY

IF6.7

2017-03-0240

PREAI

Rejection of Commonly Used Electrolytes in Asymmetric Flow Field Flow Fractionation: Effects of Membrane Molecular Weight Cutoff Size, Fluid Dynamics, and Valence of Electrolytes

IF3.9

2017-01-318

PREAI

Surface coating and matrix effect on the electrophoretic mobility of gold nanoparticles: a capillary electrophoresis-inductively coupled plasma mass spectrometry study

ANALYTICAL AND BIOANALYTICAL CHEMISTRY

IF3.8

2016-10-2530

PREAI

Polydopamine-Coated Manganese Complex/Graphene Nanocomposite for Enhanced Electrocatalytic Activity Towards Oxygen Reduction

SCIENTIFIC REPORTS

IF3.9

2016-08-1634

OAAI